Decision makers from European pharma and biotech companies will hear from two speakers at Connect in Pharma, Jean-François Hilaire (Recipharm) and Christian Wölbeling (Körber Pharma Software), on how to ensure a strong future in European pharma.
Himanshu Nivsarkar, senior manager marketing New Product Introduction, 3M Separation and Purification Sciences Division, explains the benefits and challenges of both single-use and stainless-steel bioreactors, and which is best for your facility.
David O’Connell, director of Scientific Affairs at PCI Pharma Services, Tredegar site, shares insight on how CDMOs, like PCI, can provide end-to-end solutions in the growing demand of high potency manufacturing.
Mahesh Veerina, president and CEO - ParkourSC, describe solutions that could bring improved levels of digitisation, visibility and control to pharmaceutical supply chain environments.
Christopher Brau, R&D process development manager - Thermo Fisher Scientific, explains how continuous perfusion can support small molecule manufacturers and achieve fully intensified biomanufacturing.
Natasha Rivas, vice president of quality and regulatory, and Jose Cruz, director of vector manufacturing at Genezen, explore the difficulties in ensuring cGMP compliance is achieved throughout viral vector production.
A new report sets out 20 key recommendations which, upon implementation, would set the UK on a path to become the global leader in cannabinoid innovation.
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics.
Jon Brewin, business development manager for AutoStore, discusses increasing demands on pharmaceutical supply chains and how automation can improve lead times.
